nodes	percent_of_prediction	percent_of_DWPC	metapath
Escitalopram—Citalopram—ABCB1—colon cancer	0.0113	1	CrCbGaD
Escitalopram—Anaphylactic shock—Fluorouracil—colon cancer	0.000665	0.000673	CcSEcCtD
Escitalopram—Anorexia—Irinotecan—colon cancer	0.000662	0.00067	CcSEcCtD
Escitalopram—Ataxia—Methotrexate—colon cancer	0.000662	0.00067	CcSEcCtD
Escitalopram—Infection—Fluorouracil—colon cancer	0.000661	0.000668	CcSEcCtD
Escitalopram—Haemoglobin—Capecitabine—colon cancer	0.000658	0.000665	CcSEcCtD
Escitalopram—Rhinitis—Capecitabine—colon cancer	0.000656	0.000663	CcSEcCtD
Escitalopram—Haemorrhage—Capecitabine—colon cancer	0.000654	0.000662	CcSEcCtD
Escitalopram—Hepatitis—Capecitabine—colon cancer	0.000654	0.000662	CcSEcCtD
Escitalopram—Nervous system disorder—Fluorouracil—colon cancer	0.000652	0.00066	CcSEcCtD
Escitalopram—Thrombocytopenia—Fluorouracil—colon cancer	0.000651	0.000659	CcSEcCtD
Escitalopram—Hypoaesthesia—Capecitabine—colon cancer	0.000651	0.000658	CcSEcCtD
Escitalopram—Liver function test abnormal—Methotrexate—colon cancer	0.00065	0.000657	CcSEcCtD
Escitalopram—Musculoskeletal discomfort—Vincristine—colon cancer	0.00065	0.000657	CcSEcCtD
Escitalopram—Pharyngitis—Capecitabine—colon cancer	0.000649	0.000657	CcSEcCtD
Escitalopram—Tachycardia—Fluorouracil—colon cancer	0.000649	0.000657	CcSEcCtD
Escitalopram—Hypotension—Irinotecan—colon cancer	0.000649	0.000656	CcSEcCtD
Escitalopram—Urinary tract disorder—Capecitabine—colon cancer	0.000646	0.000653	CcSEcCtD
Escitalopram—Insomnia—Vincristine—colon cancer	0.000645	0.000652	CcSEcCtD
Escitalopram—Oedema peripheral—Capecitabine—colon cancer	0.000644	0.000652	CcSEcCtD
Escitalopram—Connective tissue disorder—Capecitabine—colon cancer	0.000643	0.00065	CcSEcCtD
Escitalopram—Urethral disorder—Capecitabine—colon cancer	0.000641	0.000649	CcSEcCtD
Escitalopram—Paraesthesia—Vincristine—colon cancer	0.00064	0.000648	CcSEcCtD
Escitalopram—Breast disorder—Methotrexate—colon cancer	0.000636	0.000643	CcSEcCtD
Escitalopram—Anorexia—Fluorouracil—colon cancer	0.000634	0.000641	CcSEcCtD
Escitalopram—Toxic epidermal necrolysis—Methotrexate—colon cancer	0.000634	0.000641	CcSEcCtD
Escitalopram—Visual impairment—Capecitabine—colon cancer	0.00063	0.000638	CcSEcCtD
Escitalopram—Insomnia—Irinotecan—colon cancer	0.000628	0.000635	CcSEcCtD
Escitalopram—Paraesthesia—Irinotecan—colon cancer	0.000624	0.000631	CcSEcCtD
Escitalopram—Hypotension—Fluorouracil—colon cancer	0.000622	0.000629	CcSEcCtD
Escitalopram—Decreased appetite—Vincristine—colon cancer	0.00062	0.000627	CcSEcCtD
Escitalopram—Dyspnoea—Irinotecan—colon cancer	0.000619	0.000626	CcSEcCtD
Escitalopram—Erythema multiforme—Capecitabine—colon cancer	0.000619	0.000626	CcSEcCtD
Escitalopram—Somnolence—Irinotecan—colon cancer	0.000617	0.000624	CcSEcCtD
Escitalopram—Gastrointestinal disorder—Vincristine—colon cancer	0.000616	0.000623	CcSEcCtD
Escitalopram—Fatigue—Vincristine—colon cancer	0.000615	0.000622	CcSEcCtD
Escitalopram—Eye disorder—Capecitabine—colon cancer	0.000611	0.000618	CcSEcCtD
Escitalopram—Dyspepsia—Irinotecan—colon cancer	0.000611	0.000618	CcSEcCtD
Escitalopram—Tinnitus—Capecitabine—colon cancer	0.00061	0.000617	CcSEcCtD
Escitalopram—Pain—Vincristine—colon cancer	0.00061	0.000617	CcSEcCtD
Escitalopram—Constipation—Vincristine—colon cancer	0.00061	0.000617	CcSEcCtD
Escitalopram—Asthma—Methotrexate—colon cancer	0.000608	0.000615	CcSEcCtD
Escitalopram—Cardiac disorder—Capecitabine—colon cancer	0.000607	0.000614	CcSEcCtD
Escitalopram—Flushing—Capecitabine—colon cancer	0.000607	0.000614	CcSEcCtD
Escitalopram—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.000606	0.000613	CcSEcCtD
Escitalopram—Decreased appetite—Irinotecan—colon cancer	0.000604	0.000611	CcSEcCtD
Escitalopram—Eosinophilia—Methotrexate—colon cancer	0.000602	0.000609	CcSEcCtD
Escitalopram—Insomnia—Fluorouracil—colon cancer	0.000602	0.000608	CcSEcCtD
Escitalopram—Gastrointestinal disorder—Irinotecan—colon cancer	0.0006	0.000606	CcSEcCtD
Escitalopram—Fatigue—Irinotecan—colon cancer	0.000599	0.000606	CcSEcCtD
Escitalopram—Paraesthesia—Fluorouracil—colon cancer	0.000597	0.000604	CcSEcCtD
Escitalopram—Pancreatitis—Methotrexate—colon cancer	0.000597	0.000603	CcSEcCtD
Escitalopram—Pain—Irinotecan—colon cancer	0.000594	0.000601	CcSEcCtD
Escitalopram—Constipation—Irinotecan—colon cancer	0.000594	0.000601	CcSEcCtD
Escitalopram—Angiopathy—Capecitabine—colon cancer	0.000594	0.0006	CcSEcCtD
Escitalopram—Dyspnoea—Fluorouracil—colon cancer	0.000593	0.0006	CcSEcCtD
Escitalopram—Somnolence—Fluorouracil—colon cancer	0.000591	0.000598	CcSEcCtD
Escitalopram—Immune system disorder—Capecitabine—colon cancer	0.000591	0.000598	CcSEcCtD
Escitalopram—Mediastinal disorder—Capecitabine—colon cancer	0.00059	0.000596	CcSEcCtD
Escitalopram—Chills—Capecitabine—colon cancer	0.000587	0.000594	CcSEcCtD
Escitalopram—Dyspepsia—Fluorouracil—colon cancer	0.000585	0.000592	CcSEcCtD
Escitalopram—Arrhythmia—Capecitabine—colon cancer	0.000584	0.000591	CcSEcCtD
Escitalopram—Abdominal discomfort—Methotrexate—colon cancer	0.000583	0.00059	CcSEcCtD
Escitalopram—Gastrointestinal pain—Vincristine—colon cancer	0.000583	0.00059	CcSEcCtD
Escitalopram—Decreased appetite—Fluorouracil—colon cancer	0.000578	0.000585	CcSEcCtD
Escitalopram—Alopecia—Capecitabine—colon cancer	0.000578	0.000585	CcSEcCtD
Escitalopram—Pancytopenia—Methotrexate—colon cancer	0.000578	0.000584	CcSEcCtD
Escitalopram—Gastrointestinal disorder—Fluorouracil—colon cancer	0.000574	0.000581	CcSEcCtD
Escitalopram—Mental disorder—Capecitabine—colon cancer	0.000573	0.00058	CcSEcCtD
Escitalopram—Feeling abnormal—Irinotecan—colon cancer	0.000572	0.000579	CcSEcCtD
Escitalopram—Erythema—Capecitabine—colon cancer	0.00057	0.000576	CcSEcCtD
Escitalopram—Malnutrition—Capecitabine—colon cancer	0.00057	0.000576	CcSEcCtD
Escitalopram—Dysuria—Methotrexate—colon cancer	0.000569	0.000575	CcSEcCtD
Escitalopram—Pain—Fluorouracil—colon cancer	0.000569	0.000575	CcSEcCtD
Escitalopram—Gastrointestinal pain—Irinotecan—colon cancer	0.000568	0.000574	CcSEcCtD
Escitalopram—Upper respiratory tract infection—Methotrexate—colon cancer	0.000565	0.000572	CcSEcCtD
Escitalopram—Abdominal pain—Vincristine—colon cancer	0.000564	0.00057	CcSEcCtD
Escitalopram—Body temperature increased—Vincristine—colon cancer	0.000564	0.00057	CcSEcCtD
Escitalopram—Flatulence—Capecitabine—colon cancer	0.000561	0.000568	CcSEcCtD
Escitalopram—Erectile dysfunction—Methotrexate—colon cancer	0.00056	0.000567	CcSEcCtD
Escitalopram—Dysgeusia—Capecitabine—colon cancer	0.000558	0.000564	CcSEcCtD
Escitalopram—Photosensitivity reaction—Methotrexate—colon cancer	0.000555	0.000562	CcSEcCtD
Escitalopram—Back pain—Capecitabine—colon cancer	0.000551	0.000557	CcSEcCtD
Escitalopram—Abdominal pain—Irinotecan—colon cancer	0.000549	0.000555	CcSEcCtD
Escitalopram—Body temperature increased—Irinotecan—colon cancer	0.000549	0.000555	CcSEcCtD
Escitalopram—Feeling abnormal—Fluorouracil—colon cancer	0.000548	0.000554	CcSEcCtD
Escitalopram—Muscle spasms—Capecitabine—colon cancer	0.000548	0.000554	CcSEcCtD
Escitalopram—Pneumonia—Methotrexate—colon cancer	0.000546	0.000552	CcSEcCtD
Escitalopram—Infestation—Methotrexate—colon cancer	0.000543	0.000549	CcSEcCtD
Escitalopram—Infestation NOS—Methotrexate—colon cancer	0.000543	0.000549	CcSEcCtD
Escitalopram—Depression—Methotrexate—colon cancer	0.000541	0.000547	CcSEcCtD
Escitalopram—Stevens-Johnson syndrome—Methotrexate—colon cancer	0.000538	0.000544	CcSEcCtD
Escitalopram—Vision blurred—Capecitabine—colon cancer	0.000537	0.000543	CcSEcCtD
Escitalopram—Tremor—Capecitabine—colon cancer	0.000534	0.00054	CcSEcCtD
Escitalopram—Stomatitis—Methotrexate—colon cancer	0.000529	0.000535	CcSEcCtD
Escitalopram—Ill-defined disorder—Capecitabine—colon cancer	0.000528	0.000534	CcSEcCtD
Escitalopram—Urticaria—Fluorouracil—colon cancer	0.000528	0.000534	CcSEcCtD
Escitalopram—Conjunctivitis—Methotrexate—colon cancer	0.000527	0.000533	CcSEcCtD
Escitalopram—Anaemia—Capecitabine—colon cancer	0.000526	0.000532	CcSEcCtD
Escitalopram—Body temperature increased—Fluorouracil—colon cancer	0.000526	0.000532	CcSEcCtD
Escitalopram—Hypersensitivity—Vincristine—colon cancer	0.000525	0.000531	CcSEcCtD
Escitalopram—Sweating—Methotrexate—colon cancer	0.00052	0.000526	CcSEcCtD
Escitalopram—Haematuria—Methotrexate—colon cancer	0.000517	0.000523	CcSEcCtD
Escitalopram—Malaise—Capecitabine—colon cancer	0.000514	0.000519	CcSEcCtD
Escitalopram—Hepatobiliary disease—Methotrexate—colon cancer	0.000513	0.000519	CcSEcCtD
Escitalopram—Epistaxis—Methotrexate—colon cancer	0.000512	0.000518	CcSEcCtD
Escitalopram—Vertigo—Capecitabine—colon cancer	0.000512	0.000518	CcSEcCtD
Escitalopram—Hypersensitivity—Irinotecan—colon cancer	0.000512	0.000517	CcSEcCtD
Escitalopram—Asthenia—Vincristine—colon cancer	0.000512	0.000517	CcSEcCtD
Escitalopram—Syncope—Capecitabine—colon cancer	0.000511	0.000517	CcSEcCtD
Escitalopram—Leukopenia—Capecitabine—colon cancer	0.00051	0.000516	CcSEcCtD
Escitalopram—Agranulocytosis—Methotrexate—colon cancer	0.000506	0.000512	CcSEcCtD
Escitalopram—Palpitations—Capecitabine—colon cancer	0.000503	0.000509	CcSEcCtD
Escitalopram—Loss of consciousness—Capecitabine—colon cancer	0.000501	0.000506	CcSEcCtD
Escitalopram—Asthenia—Irinotecan—colon cancer	0.000498	0.000504	CcSEcCtD
Escitalopram—Cough—Capecitabine—colon cancer	0.000497	0.000503	CcSEcCtD
Escitalopram—Hypertension—Capecitabine—colon cancer	0.000492	0.000497	CcSEcCtD
Escitalopram—Hypersensitivity—Fluorouracil—colon cancer	0.00049	0.000496	CcSEcCtD
Escitalopram—Haemoglobin—Methotrexate—colon cancer	0.000489	0.000495	CcSEcCtD
Escitalopram—Diarrhoea—Vincristine—colon cancer	0.000488	0.000493	CcSEcCtD
Escitalopram—Hepatitis—Methotrexate—colon cancer	0.000487	0.000493	CcSEcCtD
Escitalopram—Haemorrhage—Methotrexate—colon cancer	0.000487	0.000493	CcSEcCtD
Escitalopram—Myalgia—Capecitabine—colon cancer	0.000485	0.00049	CcSEcCtD
Escitalopram—Chest pain—Capecitabine—colon cancer	0.000485	0.00049	CcSEcCtD
Escitalopram—Arthralgia—Capecitabine—colon cancer	0.000485	0.00049	CcSEcCtD
Escitalopram—Pharyngitis—Methotrexate—colon cancer	0.000483	0.000489	CcSEcCtD
Escitalopram—Anxiety—Capecitabine—colon cancer	0.000483	0.000489	CcSEcCtD
Escitalopram—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.000482	0.000487	CcSEcCtD
Escitalopram—Urinary tract disorder—Methotrexate—colon cancer	0.000481	0.000486	CcSEcCtD
Escitalopram—Discomfort—Capecitabine—colon cancer	0.000479	0.000485	CcSEcCtD
Escitalopram—Urethral disorder—Methotrexate—colon cancer	0.000477	0.000483	CcSEcCtD
Escitalopram—Diarrhoea—Irinotecan—colon cancer	0.000475	0.000481	CcSEcCtD
Escitalopram—Dry mouth—Capecitabine—colon cancer	0.000474	0.00048	CcSEcCtD
Escitalopram—Dizziness—Vincristine—colon cancer	0.000472	0.000477	CcSEcCtD
Escitalopram—Pruritus—Fluorouracil—colon cancer	0.000471	0.000476	CcSEcCtD
Escitalopram—Visual impairment—Methotrexate—colon cancer	0.000469	0.000475	CcSEcCtD
Escitalopram—Confusional state—Capecitabine—colon cancer	0.000469	0.000474	CcSEcCtD
Escitalopram—Oedema—Capecitabine—colon cancer	0.000465	0.00047	CcSEcCtD
Escitalopram—Infection—Capecitabine—colon cancer	0.000462	0.000467	CcSEcCtD
Escitalopram—Erythema multiforme—Methotrexate—colon cancer	0.00046	0.000466	CcSEcCtD
Escitalopram—Dizziness—Irinotecan—colon cancer	0.000459	0.000464	CcSEcCtD
Escitalopram—Shock—Capecitabine—colon cancer	0.000457	0.000463	CcSEcCtD
Escitalopram—Nervous system disorder—Capecitabine—colon cancer	0.000456	0.000461	CcSEcCtD
Escitalopram—Eye disorder—Methotrexate—colon cancer	0.000455	0.00046	CcSEcCtD
Escitalopram—Diarrhoea—Fluorouracil—colon cancer	0.000455	0.00046	CcSEcCtD
Escitalopram—Thrombocytopenia—Capecitabine—colon cancer	0.000455	0.00046	CcSEcCtD
Escitalopram—Tinnitus—Methotrexate—colon cancer	0.000454	0.000459	CcSEcCtD
Escitalopram—Tachycardia—Capecitabine—colon cancer	0.000454	0.000459	CcSEcCtD
Escitalopram—Vomiting—Vincristine—colon cancer	0.000453	0.000459	CcSEcCtD
Escitalopram—Cardiac disorder—Methotrexate—colon cancer	0.000452	0.000457	CcSEcCtD
Escitalopram—Skin disorder—Capecitabine—colon cancer	0.000451	0.000457	CcSEcCtD
Escitalopram—Rash—Vincristine—colon cancer	0.00045	0.000455	CcSEcCtD
Escitalopram—Hyperhidrosis—Capecitabine—colon cancer	0.000449	0.000454	CcSEcCtD
Escitalopram—Dermatitis—Vincristine—colon cancer	0.000449	0.000454	CcSEcCtD
Escitalopram—Headache—Vincristine—colon cancer	0.000447	0.000452	CcSEcCtD
Escitalopram—Anorexia—Capecitabine—colon cancer	0.000443	0.000448	CcSEcCtD
Escitalopram—Angiopathy—Methotrexate—colon cancer	0.000442	0.000447	CcSEcCtD
Escitalopram—Vomiting—Irinotecan—colon cancer	0.000442	0.000447	CcSEcCtD
Escitalopram—Immune system disorder—Methotrexate—colon cancer	0.00044	0.000445	CcSEcCtD
Escitalopram—Dizziness—Fluorouracil—colon cancer	0.00044	0.000445	CcSEcCtD
Escitalopram—Mediastinal disorder—Methotrexate—colon cancer	0.000439	0.000444	CcSEcCtD
Escitalopram—Rash—Irinotecan—colon cancer	0.000438	0.000443	CcSEcCtD
Escitalopram—Dermatitis—Irinotecan—colon cancer	0.000437	0.000442	CcSEcCtD
Escitalopram—Chills—Methotrexate—colon cancer	0.000437	0.000442	CcSEcCtD
Escitalopram—Headache—Irinotecan—colon cancer	0.000435	0.00044	CcSEcCtD
Escitalopram—Hypotension—Capecitabine—colon cancer	0.000434	0.000439	CcSEcCtD
Escitalopram—Alopecia—Methotrexate—colon cancer	0.00043	0.000435	CcSEcCtD
Escitalopram—Mental disorder—Methotrexate—colon cancer	0.000427	0.000432	CcSEcCtD
Escitalopram—Malnutrition—Methotrexate—colon cancer	0.000424	0.000429	CcSEcCtD
Escitalopram—Erythema—Methotrexate—colon cancer	0.000424	0.000429	CcSEcCtD
Escitalopram—Nausea—Vincristine—colon cancer	0.000424	0.000428	CcSEcCtD
Escitalopram—Musculoskeletal discomfort—Capecitabine—colon cancer	0.000423	0.000428	CcSEcCtD
Escitalopram—Vomiting—Fluorouracil—colon cancer	0.000423	0.000428	CcSEcCtD
Escitalopram—Insomnia—Capecitabine—colon cancer	0.00042	0.000425	CcSEcCtD
Escitalopram—Rash—Fluorouracil—colon cancer	0.000419	0.000424	CcSEcCtD
Escitalopram—Dermatitis—Fluorouracil—colon cancer	0.000419	0.000424	CcSEcCtD
Escitalopram—Paraesthesia—Capecitabine—colon cancer	0.000417	0.000422	CcSEcCtD
Escitalopram—Headache—Fluorouracil—colon cancer	0.000417	0.000421	CcSEcCtD
Escitalopram—Dysgeusia—Methotrexate—colon cancer	0.000415	0.00042	CcSEcCtD
Escitalopram—Dyspnoea—Capecitabine—colon cancer	0.000414	0.000419	CcSEcCtD
Escitalopram—Nausea—Irinotecan—colon cancer	0.000413	0.000417	CcSEcCtD
Escitalopram—Back pain—Methotrexate—colon cancer	0.00041	0.000415	CcSEcCtD
Escitalopram—Dyspepsia—Capecitabine—colon cancer	0.000409	0.000414	CcSEcCtD
Escitalopram—Decreased appetite—Capecitabine—colon cancer	0.000404	0.000409	CcSEcCtD
Escitalopram—Gastrointestinal disorder—Capecitabine—colon cancer	0.000401	0.000406	CcSEcCtD
Escitalopram—Fatigue—Capecitabine—colon cancer	0.000401	0.000405	CcSEcCtD
Escitalopram—Vision blurred—Methotrexate—colon cancer	0.0004	0.000404	CcSEcCtD
Escitalopram—Constipation—Capecitabine—colon cancer	0.000397	0.000402	CcSEcCtD
Escitalopram—Pain—Capecitabine—colon cancer	0.000397	0.000402	CcSEcCtD
Escitalopram—Nausea—Fluorouracil—colon cancer	0.000395	0.0004	CcSEcCtD
Escitalopram—Ill-defined disorder—Methotrexate—colon cancer	0.000393	0.000398	CcSEcCtD
Escitalopram—Anaemia—Methotrexate—colon cancer	0.000392	0.000396	CcSEcCtD
Escitalopram—Feeling abnormal—Capecitabine—colon cancer	0.000383	0.000387	CcSEcCtD
Escitalopram—Malaise—Methotrexate—colon cancer	0.000382	0.000387	CcSEcCtD
Escitalopram—Vertigo—Methotrexate—colon cancer	0.000381	0.000385	CcSEcCtD
Escitalopram—Gastrointestinal pain—Capecitabine—colon cancer	0.00038	0.000384	CcSEcCtD
Escitalopram—Leukopenia—Methotrexate—colon cancer	0.000379	0.000384	CcSEcCtD
Escitalopram—Cough—Methotrexate—colon cancer	0.00037	0.000374	CcSEcCtD
Escitalopram—Urticaria—Capecitabine—colon cancer	0.000369	0.000373	CcSEcCtD
Escitalopram—Body temperature increased—Capecitabine—colon cancer	0.000367	0.000372	CcSEcCtD
Escitalopram—Abdominal pain—Capecitabine—colon cancer	0.000367	0.000372	CcSEcCtD
Escitalopram—Convulsion—Methotrexate—colon cancer	0.000367	0.000372	CcSEcCtD
Escitalopram—Arthralgia—Methotrexate—colon cancer	0.000361	0.000365	CcSEcCtD
Escitalopram—Chest pain—Methotrexate—colon cancer	0.000361	0.000365	CcSEcCtD
Escitalopram—Myalgia—Methotrexate—colon cancer	0.000361	0.000365	CcSEcCtD
Escitalopram—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.000358	0.000363	CcSEcCtD
Escitalopram—Discomfort—Methotrexate—colon cancer	0.000357	0.000361	CcSEcCtD
Escitalopram—Confusional state—Methotrexate—colon cancer	0.000349	0.000353	CcSEcCtD
Escitalopram—Anaphylactic shock—Methotrexate—colon cancer	0.000346	0.00035	CcSEcCtD
Escitalopram—Infection—Methotrexate—colon cancer	0.000344	0.000348	CcSEcCtD
Escitalopram—Hypersensitivity—Capecitabine—colon cancer	0.000342	0.000346	CcSEcCtD
Escitalopram—Nervous system disorder—Methotrexate—colon cancer	0.000339	0.000343	CcSEcCtD
Escitalopram—Thrombocytopenia—Methotrexate—colon cancer	0.000339	0.000343	CcSEcCtD
Escitalopram—Skin disorder—Methotrexate—colon cancer	0.000336	0.00034	CcSEcCtD
Escitalopram—Hyperhidrosis—Methotrexate—colon cancer	0.000334	0.000338	CcSEcCtD
Escitalopram—Asthenia—Capecitabine—colon cancer	0.000333	0.000337	CcSEcCtD
Escitalopram—Anorexia—Methotrexate—colon cancer	0.00033	0.000334	CcSEcCtD
Escitalopram—Pruritus—Capecitabine—colon cancer	0.000329	0.000333	CcSEcCtD
Escitalopram—Hypotension—Methotrexate—colon cancer	0.000323	0.000327	CcSEcCtD
Escitalopram—Diarrhoea—Capecitabine—colon cancer	0.000318	0.000322	CcSEcCtD
Escitalopram—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000315	0.000319	CcSEcCtD
Escitalopram—Insomnia—Methotrexate—colon cancer	0.000313	0.000317	CcSEcCtD
Escitalopram—Paraesthesia—Methotrexate—colon cancer	0.000311	0.000314	CcSEcCtD
Escitalopram—Dyspnoea—Methotrexate—colon cancer	0.000308	0.000312	CcSEcCtD
Escitalopram—Somnolence—Methotrexate—colon cancer	0.000308	0.000311	CcSEcCtD
Escitalopram—Dizziness—Capecitabine—colon cancer	0.000307	0.000311	CcSEcCtD
Escitalopram—Dyspepsia—Methotrexate—colon cancer	0.000305	0.000308	CcSEcCtD
Escitalopram—Decreased appetite—Methotrexate—colon cancer	0.000301	0.000304	CcSEcCtD
Escitalopram—Gastrointestinal disorder—Methotrexate—colon cancer	0.000299	0.000302	CcSEcCtD
Escitalopram—Fatigue—Methotrexate—colon cancer	0.000298	0.000302	CcSEcCtD
Escitalopram—Pain—Methotrexate—colon cancer	0.000296	0.000299	CcSEcCtD
Escitalopram—Vomiting—Capecitabine—colon cancer	0.000296	0.000299	CcSEcCtD
Escitalopram—Rash—Capecitabine—colon cancer	0.000293	0.000296	CcSEcCtD
Escitalopram—Dermatitis—Capecitabine—colon cancer	0.000293	0.000296	CcSEcCtD
Escitalopram—Headache—Capecitabine—colon cancer	0.000291	0.000294	CcSEcCtD
Escitalopram—Feeling abnormal—Methotrexate—colon cancer	0.000285	0.000288	CcSEcCtD
Escitalopram—Gastrointestinal pain—Methotrexate—colon cancer	0.000283	0.000286	CcSEcCtD
Escitalopram—Nausea—Capecitabine—colon cancer	0.000276	0.000279	CcSEcCtD
Escitalopram—Urticaria—Methotrexate—colon cancer	0.000275	0.000278	CcSEcCtD
Escitalopram—Body temperature increased—Methotrexate—colon cancer	0.000274	0.000277	CcSEcCtD
Escitalopram—Abdominal pain—Methotrexate—colon cancer	0.000274	0.000277	CcSEcCtD
Escitalopram—Hypersensitivity—Methotrexate—colon cancer	0.000255	0.000258	CcSEcCtD
Escitalopram—Asthenia—Methotrexate—colon cancer	0.000248	0.000251	CcSEcCtD
Escitalopram—Pruritus—Methotrexate—colon cancer	0.000245	0.000248	CcSEcCtD
Escitalopram—Diarrhoea—Methotrexate—colon cancer	0.000237	0.000239	CcSEcCtD
Escitalopram—Dizziness—Methotrexate—colon cancer	0.000229	0.000231	CcSEcCtD
Escitalopram—Vomiting—Methotrexate—colon cancer	0.00022	0.000223	CcSEcCtD
Escitalopram—Rash—Methotrexate—colon cancer	0.000218	0.000221	CcSEcCtD
Escitalopram—Dermatitis—Methotrexate—colon cancer	0.000218	0.00022	CcSEcCtD
Escitalopram—Headache—Methotrexate—colon cancer	0.000217	0.000219	CcSEcCtD
Escitalopram—Nausea—Methotrexate—colon cancer	0.000206	0.000208	CcSEcCtD
